Award recordCONTRACT

CORGENIX MEDICAL CORPORATION

PIID VA25914A0174· VHA· 259-NETWORK CONTRACT OFFICE 19· 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS· FY2014· $0 net obligations· UEI LL3JF6BUDL58· CO

Description

IGF::OT::IGF ANTI-CARDIOLIPIN TEST KITS FOR IGG AND IGM TESTING AT ECHCS

First action · last action
2014-09-30 · 2016-01-22
Transactions
2
First transaction's obligation
$0
Base + all options value (sum of deltas)
$145,000
Extent competed
—
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1$0Base award · 2014-09-30 · this action $0 · running total $0Modification P00001 · 2016-01-22 · this action $0 · running total $0
  • Base2014-09-30+$0= $0
  • Mod P000012016-01-22+$0= $0
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2014-09-30+$0$0IGF::OT::IGF ANTI-CARDIOLIPIN TEST KITS FOR IGG AND IGM TESTING AT ECHCS
Mod P00001· CHANGE ORDER2016-01-22+$0$0IGF::OT::IGF ANTI-CARDIOLIPIN TEST KITS FOR IGG AND IGM TESTING AT ECHCS

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI LL3JF6BUDL58)

AwardOffice · PSC / listingNet obligationsFY
36C25918N2695NETWORK CONTRACT OFFICE 19 (36C259) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$7,100FY2018
VA25917J4606NETWORK CONTRACT OFFICE 19 (36C259) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$17,040FY2017
VA25916J0001NETWORK CONTRACT OFFICE 19 (36C259) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$13,103FY2016
VA25915J5974259-NETWORK CONTRACT OFFICE 19 · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$12,785FY2015
VA25914J4173259-NETWORK CONTRACT OFFICE 19 · Q301 · MEDICAL- LABORATORY TESTING$16,102FY2014
VA25914D0347259-NETWORK CONTRACT OFFICE 19 · Q301 · MEDICAL- LABORATORY TESTING$0FY2014

Other recipients under 6550 from 259-NETWORK CONTRACT OFFICE 19 (most recent first)

AwardRecipientOfficeNet obligationsFY
VA25915J5011NANOSPHERE, LLC259-NETWORK CONTRACT OFFICE 19$80,000FY2016
VA25915P0649CEPHEID259-NETWORK CONTRACT OFFICE 19$73,516FY2015
VA25915J5964NANOSPHERE, LLC259-NETWORK CONTRACT OFFICE 19$78,797FY2015
VA25914J2859ABBOTT LABORATORIES INC.259-NETWORK CONTRACT OFFICE 19$86,964FY2014
VA25913J1385ABBOTT LABORATORIES INC.259-NETWORK CONTRACT OFFICE 19$96,802FY2013

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_VA25914A0174_3600 · retrieved 2026-09-26.